Citations to this article

Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.
W A Marasco, … , W A Haseltine, J Sodroski
W A Marasco, … , W A Haseltine, J Sodroski
Published October 1, 1992
Citation Information: J Clin Invest. 1992;90(4):1467-1478. https://doi.org/10.1172/JCI116014.
View: Text | PDF
Research Article

Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Abstract

The F105 mAb, identified in an HIV-1-infected individual, binds to a discontinuous epitope on the HIV-1 gp120 envelope glycoprotein, blocks the binding of gp120 to the CD4 viral receptor, and neutralizes a broad range of HIV-1 isolates. This study reports the primary nucleotide and deduced amino acid sequences of the rearranged heavy and light chains of the mAb F105. This IgG1k mAb uses a VH gene member of the VH4 gene family (V71-4) and is productively rearranged with a D-D fusion product of the dlr4 and da4 germline DH genes and the JH5 gene. This rearranged heavy chain gene expresses the VH4-HV2a idiotope, which is seen in human monoclonal IgM cold agglutinins. The F105 Vk appears to be derived from the Humvk325 germline gene and is rearranged with a Jk2 gene. For both chains, the mutational pattern in the rearranged VH and VL genes is indicative of an antigen-driven process. These studies show that production of a broadly neutralizing anti-HIV-1 antibody that recognizes determinants within the CD4 recognition site of the envelope glycoprotein is achieved by rearrangement of the V71-4 and Humvk325 germline variable region genes along with selected individual point mutations in the rearranged genes.

Authors

W A Marasco, J Bagley, C Zani, M Posner, L Cavacini, W A Haseltine, J Sodroski

×

Total citations by year

Year: 2024 2023 2016 2015 2009 2004 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 Total
Citations: 1 1 1 1 2 1 2 2 2 1 4 4 3 9 6 5 45
Citation information

Citations to this article (45)

Title and authors Publication Year
Priming antibody responses to the fusion peptide in rhesus macaques
Cottrell CA, Pratap PP, Cirelli KM, Carnathan DG, Enemuo CA, Antanasijevic A, Ozorowski G, Sewall LM, Gao H, Allen JD, Nogal B, Silva M, Bhiman J, Pauthner M, Irvine DJ, Montefiori D, Crispin M, Burton DR, Silvestri G, Crotty S, Ward AB 		npj Vaccines 2024
Focusing antibody responses to the fusion peptide in rhesus macaques
Cottrell CA, Pratap PP, Cirelli KM, Carnathan DG, Enemuo CA, Antanasijevic A, Ozorowski G, Sewall LM, Gao H, Greene KM, Allen JD, Ngo JT, Choe Y, Nogal B, Silva M, Bhiman J, Pauthner M, Irvine DJ, Montefiori D, Crispin M, Burton DR, Silvestri G, Crotty S, Ward AB 		2023
Ig Constant Region Effects on Variable Region Structure and Function
A Janda, A Bowen, NS Greenspan, A Casadevall 		Frontiers in microbiology 2016
Vectored antibody gene delivery for the prevention or treatment of HIV infection:
CE Deal, AB Balazs 		Current Opinion in HIV and AIDS 2015
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens
X Xiao, W Chen, Y Feng, Z Zhu, P Prabakaran, Y Wang, MY Zhang, NS Longo, DS Dimitrov 		Biochemical and Biophysical Research Communications 2009
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1
MK Gorny, XH Wang, C Williams, B Volsky, K Revesz, B Witover, S Burda, M Urbanski, P Nyambi, C Krachmarov, A Pinter, S Zolla-Pazner, A Nadas 		Molecular Immunology 2009
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120
S Masiero, CD Vecchio, R Gavioli, G Mattiuzzo, MG Cusi, L Micheli, F Gennari, A Siccardi, WA Marasco, G Palù, C Parolin 		Gene Therapy 2004
The Selective Regulation of α V β 1 Integrin Expression Is Based on the Hierarchical Formation of α V -containing Heterodimers
P Koistinen, J Heino 		The Journal of biological chemistry 2002
Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes
AM Mhashilkar, C Doebis, M Seifert, A Busch, C Zani, JS Hoo, M Nagy, T Ritter, HD Volk, WA Marasco 		Gene Therapy 2002
Nucleotide sequence analysis of a human monoclonal antibody TONO-1 with cytotoxic potential for T-leukemia/lymphoma cells
M Numasaki, K Nakamura, Y Fukuoka, H Saeki, N Hanai, T Kudo 		Immunology Letters 2001
Molecular determinants of the human antibody response to HIV-1: implications for disease control
M Viau, M Zouali 		Journal of Clinical Immunology 2001
Aberrant Expression of Immunoglobulin Heavy Chain Genes in Epstein-Barr Virus-Negative, Human Immunodeficiency Virus-Related Lymphoid Interstitial Pneumonia
K Kurosu, N Yumoto, WN Rom, J Jaishree, K Nakata, T Kuriyama, A Mikata, MD Weiden 		Laboratory Investigation 2000
The Human Anti-bullous Pemphigoid Monoclonal Autoantibody P22 is Encoded by Genes of the IGHV4 and IGLV4 Families
V Francès, C Guret, F Malisan, E Peyron, S Ho, MJ Maat, F Fossiez, JF Nicolas, S Lebecque, H Martinez-Valdez 		Journal of Autoimmunity 2000
Depletion of αV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis
P Koistinen, T Pulli, VJ Uitto, L Nissinen, T Hyypiä, J Heino 		Matrix Biology 1999
Molecular Characterization of Five Neutralizing Anti-HIV Type 1 Antibodies: Identification of Nonconventional D Segments in the Human Monoclonal Antibodies 2G12 and 2F5
R Kunert, F Rüker, H Katinger 		AIDS Research and Human Retroviruses 1998
Functional and Molecular Characterization of Human Monoclonal Antibody Reactive with the Immunodominant Region of HIV Type 1 Glycoprotein 41
LA Cavacini, CL Emes, AV Wisnewski, J Power, G Lewis, D Montefiori, MR Posner 		AIDS Research and Human Retroviruses 1998
Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120
N Bitton, F Verrier, P Debré, G Gorochov 		European Journal of Immunology 1998
Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection
L Juompan, P Lambin, M Zouali 		The FASEB Journal 1998
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17
R Levin, AM Mhashilkar, T Dorfman, A Bukovsky, C Zani, J Bagley, J Hinkula, M Niedrig, J Albert, B Wahren, HG Göttlinger, WA Marasco 		Molecular Medicine 1997
INTRACELLULAR ANTIBODIES (INTRABODIES) FOR GENE THERAPY OF INFECTIOUS DISEASES
IJ Rondon, WA Marasco 		Annual Review of Microbiology 1997
Idiotypes in Medicine: Autoimmunity, Infection and Cancer
TJ Kunicki, DJ Nugent 		Idiotypes in Medicine: Autoimmunity, Infection and Cancer 1997
Intracellular Antibodies
A Cattaneo, S Biocca 		1997
Nonrandom features of the human immunoglobulin variable region gene repertoire expressed in response to HIV-1
M Zouali 		Applied Biochemistry and Biotechnology 1996
Characteristics of human antibody repertoires following active immune responses in vivo
M Ohlin, CA Borrebaeck 		Molecular Immunology 1996
Review: Human Antibody Variable Region Gene Usage in HIV-1 Infection
A Wisnewski, L Cavacini, M Posner 		Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996
The human antibody repertoire: Heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigens
JS Andris, SR Abraham, V Pascual, MP Pistillo, S Mantero, GB Ferrara, JD Capra 		Molecular Immunology 1995
B-cell superantigens: implications for selection of the human antibody repertoire
M Zouali 		Immunology Today 1995
Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression
D David, D Goossens, C Desgranges, J Thèze, M Zouali 		Immunology Letters 1995
Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor
JH Richardson, JG Sodroski, TA Waldmann, WA Marasco 		Proceedings of the National Academy of Sciences 1995
Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies
AM Mhashilkar, J Bagley, SY Chen, AM Szilvay, DG Helland, WA Marasco 		The EMBO Journal 1995
The molecular structure of human antibodies specific for the human immunodeficiency virus
JS Andris, JD Capra 		Journal of Clinical Immunology 1995
Characterization of the variable regions of a chimpanzee monoclonal antibody with potent neutralizing activity against HIV-1
S Vijh-Warrier, E Murphy, I Yokoyama, SA Tilley 		Molecular Immunology 1995
Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy
WA Marasco 		Immunotechnology 1995
Section Review: Biologicals & Immunologicals: Intracellular antibodies for HIV-1 gene therapy
SY Chen, AM Mhashikar, WA Marasco 		Expert Opinion on Investigational Drugs 1995
Cloning and Characterisation of TPO Autoantibodies Using Combinatorial Phage Display Libraries
MJ Hexham, JI Partridge, J Furmaniak, BV Petersen, CJ Colls, C Pegg, RB Smith, RD Burton 		Autoimmunity 1994
Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide
AH Lucas, JW Larrick, DC Reason 		Infection and immunity 1994
Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody
SY Chen, Y Khouri, J Bagley, WA Marasco 		Proceedings of the National Academy of Sciences 1994
Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120
J Bagley, PJ Dillon, C Rosen, J Robinson, J Sodroski, WA Marasco 		Molecular Immunology 1994
Intracellular Antibodies as a New Class of Therapeutic Molecules for Gene Therapy
SY Chen, J Bagley, WA Marasco 		Human Gene Therapy 1994
Molecular Characterization of Variable Heavy and Light Chain Regions of Five HIV Type 1-Specific Human Monoclonal Antibodies*
ER van der DONK, M Schutten, AD Osterhaus, RO van der HEIJDEN 		AIDS Research and Human Retroviruses 1994
Molecular characterization of human antibodies to bacterial antigens: Utilization of the less frequently expressed VH2 and VH6 heavy chain variable region gene families
JS Andris, BR Brodeur, JD Capra 		Molecular Immunology 1993
Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus
KD Bell, O Ramilo, ES Vitetta 		Proceedings of the National Academy of Sciences 1993
Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody
WA Marasco, WA Haseltine, SY Chen 		Proceedings of the National Academy of Sciences 1993
Intrazelluläre Antikörper
A Maelicke 		Nachrichten aus Chemie, Technik und Laboratorium 1993
Content and dynamics of the human antibody variable region repertoire to the Haemophilus influenzae type b polysaccharide
DC Reason, AH Lucas 		Springer Seminars in Immunopathology 1993

Advertisement